IOL Chemicals & Pharmaceuticals Current Share Price | IOL Chemicals & Pharmaceuticals Stock Screener
IOLCP
Pharmaceuticals
IOL Chemicals & Pharmaceuticals Current Stock Price Today
Live Share Price NSE
₹203.15
▲
5.66 (2.87%)
Live Share Price BSE
₹202.95
▲
5.50 (2.79%)
As of September 18, 2026, the live IOL Chemicals & Pharmaceuticals share price (NSE: IOLCP) is ₹203.15 on NSE and ₹202.95 on BSE, up 2.87% from the previous close, with shares trading between ₹195.70 and ₹206.00 in today's trading session, and a 52-week range of ₹68.21–₹213.04.
Browse IOLCP complete financial statements to support your investment research.
Use the IOL Chemicals & Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
IOL Chemicals & Pharmaceuticals Market Cap
₹5,703.53 Cr.
IOLCP P/E Ratio (TTM)
36.88
IOL Chemicals & Pharmaceuticals P/B Ratio
3.45
EPS (TTM)
₹4.69
Dividend Yield
0.47%
Debt to Equity
0.07
IOLCP 52 Week High
₹213.04
IOL Chemicals & Pharmaceuticals 52 Week Low
₹68.21
Operating Margin
14.00%
Profit Margin
8.38%
IOLCP Revenue (TTM)
₹764.00
EBITDA
₹112.00
Net Income
₹64.00
Total Assets
₹2,587.00
Total Equity
₹1,799.00
IOL Chemicals & Pharmaceuticals Current Share Price Chart
Track the current IOL Chemicals & Pharmaceuticals share price and stock price with an interactive chart. Analyse IOLCP price trends, trading volume, historical performance, and volatility across different timeframes — the complete IOL Chemicals & Pharmaceuticals stock quote in one place.
IOL Chemicals & Pharmaceuticals Company Profile - Fundamental Screener
Screen IOL Chemicals & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for IOLCP shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE485C01029
IOL Chemicals & Pharmaceuticals Balance Sheet Screener
Screen IOLCP balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 2,587 | 2,382 | 2,244 | 2,022 | 1,962 |
| Current Assets | 1,228 | 1,151 | 1,120 | 920 | 1,081 |
| Fixed Assets | 1,182 | 1,171 | 933 | 752 | 561 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 98 | 85 | 73 | 58 | 57 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 1,799 | 1,688 | 1,612 | 1,508 | 1,392 |
| Share Capital | 59 | 59 | 59 | 59 | 59 |
| Reserves & Surplus | 1,740 | 1,629 | 1,553 | 1,449 | 1,334 |
IOL Chemicals & Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen IOL Chemicals & Pharmaceuticals income statement and profit fundamentals.
Analyze IOLCP quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for IOL Chemicals & Pharmaceuticals share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 764 | 621 | 586 | 574 | 559 | 532 | 527 | 532 | 510 | 511 | 529 | 552 | 570 | 596 | 530 |
| Expenses | 653 | 527 | 534 | 511 | 490 | 465 | 476 | 484 | 451 | 454 | 476 | 481 | 491 | 492 | 481 |
| EBITDA | 112 | 94 | 51 | 64 | 70 | 67 | 51 | 48 | 59 | 57 | 53 | 71 | 80 | 104 | 49 |
| Operating Profit % | 14.00% | 15.00% | 8.00% | 10.00% | 11.00% | 12.00% | 9.00% | 8.00% | 10.00% | 10.00% | 9.00% | 12.00% | 13.00% | 16.00% | 8.00% |
| Depreciation | 21 | 20 | 20 | 20 | 20 | 19 | 19 | 18 | 17 | 16 | 16 | 16 | 14 | 12 | 12 |
| Interest | 4 | 3 | 4 | 4 | 4 | 4 | 5 | 4 | 2 | 3 | 4 | 4 | 4 | 5 | 5 |
| Profit Before Tax | 87 | 71 | 28 | 41 | 46 | 45 | 28 | 26 | 40 | 37 | 32 | 51 | 61 | 87 | 33 |
| Tax | 22 | 18 | 7 | 11 | 12 | 13 | 7 | 7 | 10 | 10 | 9 | 13 | 15 | 22 | 9 |
| Net Profit | 64 | 53 | 21 | 30 | 34 | 31 | 21 | 19 | 30 | 28 | 23 | 38 | 46 | 65 | 24 |
| EPS | 2.19 | 1.81 | 0.70 | 1.02 | 1.16 | 1.07 | 3.50 | 3.26 | 5.11 | 4.71 | 3.93 | 6.45 | 7.81 | 11.03 | 4.05 |
IOL Chemicals & Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen IOLCP cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
| Operating Activities | 214 | 179 | 290 | 122 | 93 |
| Investing Activities | -198 | -154 | -191 | -120 | -121 |
| Financing Activities | -29 | 46 | -93 | -4 | -2 |
| Net Cash Flow | -13 | 71 | 6 | -2 | -29 |
IOL Chemicals & Pharmaceuticals Shareholding Pattern Screener
See IOL Chemicals & Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check IOL Chemicals & Pharmaceuticals promoter holding and ownership changes for IOLCP on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 62.28% | 57.48% | 52.62% | 52.62% | 52.62% | 52.62% | 52.62% | 48.19% |
| FII Holding | 4.87% | 1.72% | 2.08% | 2.25% | 2.59% | 1.47% | 1.49% | 1.63% |
| DII Holding | 0.43% | 0.02% | 0.03% | 0.04% | 0.02% | 0.07% | 0.08% | 0.08% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.95% | 31.03% | 30.51% | 29.97% | 30.22% | 31.43% | 31.23% | 31.31% |
| Other Holding | 5.47% | 9.74% | 14.76% | 15.12% | 14.54% | 14.40% | 14.58% | 18.79% |
| Shareholder Count | 119,311 | 131,550 | 133,531 | 136,129 | 125,040 | 130,002 | 126,701 | 125,979 |
IOL Chemicals & Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check IOL Chemicals & Pharmaceuticals dividend history with payout and yield data.
View IOL Chemicals & Pharmaceuticals dividend details including ex-dates and amounts for IOLCP stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹1.00 | 0.51% |
| 2025-March | ₹0.80 | 1.10% |
| 2024-March | ₹5.00 | 8.18% |
| 2023-March | ₹4.00 | 5.53% |
| 2022-March | ₹4.00 | 7.07% |
| 2021-March | ₹6.00 | 8.48% |
| 2020-March | ₹3.00 | 2.72% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
IOL Chemicals & Pharmaceuticals Stock Index Membership
See which indices include IOL Chemicals & Pharmaceuticals stock.
Check IOLCP index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
IOL Chemicals & Pharmaceuticals Market Events Screener - Corporate Actions
Get IOL Chemicals & Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check IOL Chemicals & Pharmaceuticals stock events that may affect IOLCP share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-02 | 2026-09-02 | Annual General Meeting | NA | 72.83% |
| 2026-08-10 | 2026-08-10 | Quarterly Result Announcement | NA | 14.67% |
| 2026-05-20 | 2026-05-20 | Quarterly Result Announcement | NA | 4.26% |
| 2026-02-17 | 2026-02-17 | Dividend | ₹ 1.00 /share | -7.50% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 12.36% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -5.32% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | 27.43% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 0.92% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 18.62% |
| 2025-03-11 | 2025-03-11 | Split | 2:10 | -16.00% |
| 2025-02-18 | 2025-02-18 | Dividend | ₹ 4.00 /share | -7.33% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | 1.31% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -6.34% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | 24.87% |
| 2024-02-16 | 2024-02-16 | Dividend | ₹ 5.00 /share | -6.06% |
IOL Chemicals & Pharmaceuticals Competitors Screener - Peer Comparison
Screen IOLCP competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
IOL Chemicals & Pharmaceuticals Company Announcements - News Screener
Screen IOLCP latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-09-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-16 | Expansion Of Ibuprofen Capacity New CDMO Business For Pharmaceutical Formulations And Dedicated Specialty Chemicals Manufacturing Facility | - |
| 2026-09-02 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-02 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-20 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-11 | Communication To The Shareholders Regarding AGM Notice And Annual Report For The Financial Year 2025-26 | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-10 | Outcome Of The Board Meeting And Submission Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026 | - |
| 2026-08-10 | Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026 | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-07 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-07 | Submission Of Notice Of The 39Th Annual General Meeting | - |
| 2026-08-07 | Reg. 34 (1) Annual Report. | - |